Pediatric COVID-19: Immunopathogenesis, Transmission and Prevention
Related Experiment Video
Updated: Oct 18, 2025
Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Geraldine Blanchard-Rohner1,2,3, Arnaud Didierlaurent2, Anne Tilmanne4
1Center of Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland.
Insights
Children infected with SARS-CoV-2, the virus that causes COVID-19, experience milder illness compared to adults. However, a unique inflammatory syndrome can occur, necessitating careful consideration for pediatric COVID-19 vaccination strategies.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Public Health
Background:
- Children exhibit distinct responses to SARS-CoV-2 compared to adults, with generally lower disease severity.
- This contrasts with their higher susceptibility to other respiratory infections, suggesting unique immune mechanisms.
- A severe complication, multisystem inflammatory syndrome in children (MIS-C), can arise weeks post-infection.
Purpose of the Study:
- To analyze the unique epidemiological and clinical characteristics of COVID-19 in pediatric populations.
- To evaluate the implications of these characteristics for the benefit-risk assessment of pediatric COVID-19 vaccination.
- To understand the role of children in SARS-CoV-2 transmission dynamics.
Main Methods:
- Review and synthesis of existing literature on pediatric COVID-19.
- Analysis of epidemiological data regarding infection rates, severity, and transmission in children.
- Discussion of immunological responses and the pathogenesis of MIS-C.
Main Results:
- Children are less likely to develop severe COVID-19, with higher rates of asymptomatic infection compared to adults.
- Pediatric contribution to SARS-CoV-2 transmission appears lower than that of adults.
- Multisystem inflammatory syndrome in children (MIS-C) is a significant, albeit rare, complication.
Conclusions:
- The distinct clinical profile of COVID-19 in children, including lower severity and unique complications like MIS-C, must inform vaccination strategies.
- Ongoing vaccination of adolescents and studies in younger children will provide crucial data on vaccine impact on health and community transmission.
- Further research into the underlying immune mechanisms is warranted.
Abstract:
Children are unique in the context of the COVID-19 pandemic. Overall, SARS-CoV-2 has a lower medical impact in children as compared to adults. A higher proportion of children than adults remain asymptomatic following SARS-CoV-2 infection and severe disease and death are also less common. This relative resistance contrasts with the high susceptibility of children to other respiratory tract infections. The mechanisms involved remain incompletely understood but could include the rapid development of a robust innate immune response. On the other hand, children develop a unique and severe complication, named multisystem inflammatory syndrome in children, several weeks after the onset of symptoms. Although children play an important role in the transmission of many pathogens, their contribution to the transmission of SARS-CoV-2 appears lower than that of adults. These unique aspects of COVID-19 in children must be considered in the benefit-risk analysis of vaccination. Several COVID-19 vaccines have been authorized for emergency use in adolescents and clinical studies are ongoing in children. As the vaccination of adolescents is rolled out in several countries, we shall learn about the impact of this strategy on the health of children and on transmission within communities.
More Related Videos
Related Concept Videos
01:20Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:51Vaccinations
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...